Using similar methods to induce Nrf1 and Nrf2, here we investigated whether more prolonged induction of Nrf1, Nrf2, or both may alleviate MASH and fibrosis in a MASH-linked fibrosis model. The gene discussed is NRF1; the disease is metabolic dysfunction-associated steatohepatitis.